Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Louisiana Blue | 00029 Dynamic Orthotic Cranioplasty - Retired Policy | New policy |
| Aug 2, 2026 | Louisiana Blue | 00025 Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy-Retired Policy | New policy |
| Aug 2, 2026 | Louisiana Blue | 00018 Combined Androgen Blockade for the Treatment of Metastatic Prostate Cancer - Retired Policy | New policy |
| Aug 2, 2026 | Louisiana Blue | 00013 CA-125-Retired Policy | New policy |
| Aug 2, 2026 | Louisiana Blue | 00008 Automatic Implantable Cardioverter Defibrillator (AICD)-Retired Policy | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Zynteglo | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Zolgensma Medical Drug Criteria | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Zevaskyn (Topical) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Wireless Capsule Endoscopy for Gastrointestinal (GI) Disorders | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Wearable Cardioverter Defibrillators | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Vyjuvek | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Video Electroencephalogram (EEG) Monitoring | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Varicose Veins | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Vagus Nerve Stimulation | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Tumor Treating Fields Therapy | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Treatment of Hyperhidrosis | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Treatment for Duchenne Muscular Dystrophy | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Transcranial Magnetic Stimulation (TMS) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Transcatheter Aortic Valve Implantation for Aortic Stenosis | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Total Artificial Hearts and Ventricular Assist Devices | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Tibial Nerve Stimulation | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Testing Serum Vitamin D Levels | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Temporomandibular Joint (TMJ) Disorder | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Surgical Treatment of Snoring and Obstructive Sleep Apnea (OSA) Syndrome | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Surgical Treatment of Gynecomastia | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Surgical Treatment of Femoroacetabular Impingement | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Surgical Treatment for Gender Dysphoria | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Surgical Deactivation of Headache Trigger Sites | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Steroid-Eluting Sinus Stents and Implants | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Stereotactic Radiosurgery and Stereotactic Body Radiotherapy | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Spinal Cord and Dorsal Root Ganglion Stimulation | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Sphenopalatine Ganglion Block for Headache | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Skysona | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Serum Antibodies for the Diagnosis of Inflammatory Bowel Disease | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Serologic Diagnosis of Celiac Disease | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Scanning Computerized Ophthalmic Diagnostic Imaging Devices | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Sacral Nerve Neuromodulation / Stimulation | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Roctavian | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Risk-Reducing Mastectomy | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Rethymic | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Reduction Mammaplasty for Breast-Related Symptoms | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Recombinant and Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non‒Orthopedic Conditions | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Radiofrequency Ablation of Primary or Metastatic Liver Tumors | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Radiofrequency Ablation (RFA) of Miscellaneous Solid Tumors Excluding Liver Tumors | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Radioembolization for Primary and Metastatic Tumors of the Liver | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Proteomic Testing for Systemic Therapy in Non-Small-Cell Lung Cancer | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Prostatic Urethral Lift | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Kansas | Prostate Artery Embolization for Benign Hyperplasia | New policy |